Epsilon M&A Deal Report - Nizoral Shampoo Brand Rights in EMEA
Transaction Multiples for the Valuation of Private Companies
STADA Arzneimittel / Nizoral Shampoo Brand Rights in EMEA
No EMAT :
94522
Announced Date :
25/06/2018
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
STADA Arzneimittel
Target :
Nizoral Shampoo Brand Rights in EMEA
Country :
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Personal Products
Business Description :
Nizoral Shampoo is a medicated anti-druff shampoo . > Nizoral’s market share in the EMEA region is several times that of its nearest competitor, making it the clear market leader among medicated...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|||||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Personal Products » = 127
| Date | Acquirer | Target | Country | Multiples | See details |
| 12/02/2018 | Private Group led by 3i Group | Koninklijke Sanders (Royal Sanders) | Netherlands | * | 94516 |
| 03/09/2018 | The Hut Group (THG) | Acheson & Acheson | England | ** | 94493 |
Source: Epsilon Research / EMAT
